Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004961973 | SCV005469503 | uncertain significance | Inborn genetic diseases | 2024-11-08 | criteria provided, single submitter | clinical testing | The c.12206G>A (p.G4069E) alteration is located in exon 45 (coding exon 45) of the PKD1 gene. This alteration results from a G to A substitution at nucleotide position 12206, causing the glycine (G) at amino acid position 4069 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |